Our reports provide an independent, expert view supported by robust and innovative data interrogation and analysis.

Sort by:
Frontier Pharma: Schizophrenia - Diverse First-in-Class Pipeline Shows Promise for Treatment of Negative and Cognitive Symptoms

Published: May-2018

Schizophrenia is a chronic mental disorder that affects 1% of the population – equivalent to 51 million people.....

$6995
More Info
Breast Cancer Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Increasing Uptake of Targeted Therapies and Rising Prevalence

Published: May-2018

Breast cancer is the second most common cancer in the world overall, and the most common cancer in women. When diagnosed.....

$4995
More Info
The Mid-Size Pharmaceutical Market: Market Assessment, Growth Forecasts and Strategic Consolidations for Key Players

Published: May-2018

GBI Research’s latest report, The Mid-Size Pharmaceutical Market: Market Assessment, Growth Forecasts and Strategic.....

$2995
More Info
Frontier Pharma: Type 2 Diabetes Mellitus - Therapies Targeting GPCRs and Protein Kinases Dominate Pipeline, with Strong Repositioning Opportunities into Associated Areas, Including Obesity and Cardiovascular Disease

Published: Apr-2018

Type 2 diabetes mellitus (T2DM) is a major metabolic disease and one of the leading causes of death worldwide. The prevalence.....

$6995
More Info
Cognitive Impairment Disorders Drug Development Pipeline Review, 2018

Published: Apr-2018

This report provides an overview of the pipeline landscape for cognitive impairment disorders. It provides comprehensive.....

$3995
More Info
Influenza A Viral Infections Drug Development Pipeline Review, 2018

Published: Apr-2018

This report provides an overview of the pipeline landscape for influenza A viral infections. It provides comprehensive.....

$3995
More Info
Respiratory Syncytial Virus and Human Parainfluenza Virus 3 Infections Drug Development Pipeline Review, 2018

Published: Apr-2018

This report provides an overview of the pipeline landscape for the respiratory tract infections respiratory syncytial.....

$3995
More Info
Global Immunology Drugs Market to 2023 - Shifting Landscape as Uptake of Interleukin Receptor Inhibitors Offsets Losses for Top Blockbuster Drugs

Published: Mar-2018

Immune-mediated inflammatory diseases are a common set of chronic disorders that affect 5–7% of people in Western.....

$4995
More Info
HAE Therapeutics in Asia-Pacific Markets to 2023 - Growth Driven by Ongoing Shift towards Plasma-Derivative Products and Expected Launch of Premium Therapies

Published: Mar-2018

Hereditary Angioedema (HAE) is a rare genetic disorder caused by a lack of a sufficient amount of a protein called C1.....

$4995
More Info
Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2023 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs

Published: Mar-2018

Rheumatoid Arthritis (RA) is a chronic, progressive and currently incurable autoimmune disease that primarily affects.....

$4995
More Info
Sort by: